PTC Therapeutics, Inc. - Common Stock (NQ:PTCT)

75.56 +2.09 (+2.85%)

Streaming Delayed Price Updated: 3:06 PM EST, Dec 10, 2025 Add to My Watchlist

Price and Volume

Volume	418,945
Open	73.87
Bid (Size)	75.36 (400)
Ask (Size)	75.62 (400)
Prev. Close	73.47
Today's Range	73.44 - 75.62
52wk Range	35.95 - 87.50
Shares Outstanding	79,931,766
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

PTC Therapeutics Inc (NASDAQ:PTCT): A GARP Stock with Strong Growth and Reasonable Valuation ↗

Today 8:31 EST

PTC Therapeutics offers high growth at a fair price, with strong earnings and revenue increases, trading below industry valuations.

Via Chartmill

Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗

December 03, 2025

One specialist investor just walked away from STAAR Surgical entirely—right as uncertainty over a delayed Alcon deal looms.

Via The Motley Fool

Performance

YTD	+64.7%	+64.7%
1 Month	+4.3%	+4.3%
3 Month	+29.3%	+29.3%
6 Month	+46.0%	+46.0%
1 Year	+57.2%	+57.2%

More News

PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? ↗

December 03, 2025

Via The Motley Fool

Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? ↗

December 03, 2025

Via The Motley Fool

Rare-Disease Biotech PTC Is Surging — And One Fund Just Raised Its Bet. Should You? ↗

December 02, 2025

Via The Motley Fool

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

Via MarketMinute

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? ↗

December 02, 2025

Via The Motley Fool

A PTC Therapeutics (PTCT) Insider Sold 10,000 Shares for $795,000 ↗

November 29, 2025

Via The Motley Fool

PTC THERAPEUTICS INC (NASDAQ:PTCT) Presents an Affordable Growth Opportunity ↗

November 19, 2025

Via Chartmill

This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why ↗

November 18, 2025

Via The Motley Fool

Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally ↗

November 18, 2025

Via The Motley Fool

PTC THERAPEUTICS INC (NASDAQ:PTCT) Shows Strong Growth Momentum and Technical Health ↗

November 13, 2025

Via Chartmill

Sarepta Therapeutics Shares Plummet as Key DMD Treatments Miss Primary Endpoint in Late-Stage Trial

November 04, 2025

Via MarketMinute

PTC THERAPEUTICS INC (NASDAQ:PTCT) Presents a Compelling Mix of Strong Growth and Bullish Technical Setup ↗

October 30, 2025

Via Chartmill

PTC THERAPEUTICS INC (NASDAQ:PTCT) Presents an Affordable Growth Opportunity ↗

October 25, 2025

Via Chartmill

PTC THERAPEUTICS INC (NASDAQ:PTCT) Presents a Compelling Case for Affordable Growth Investing ↗

October 02, 2025

Via Chartmill

PTC THERAPEUTICS INC (NASDAQ:PTCT) Combines Strong Growth with Bullish Technical Setup ↗

September 30, 2025

Via Chartmill

PTC THERAPEUTICS INC (NASDAQ:PTCT): An Affordable Growth Candidate in Biotech ↗

September 11, 2025

Via Chartmill

PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment ↗

September 08, 2025

Via Benzinga

Here's Why Shares in PTC Therapeutics Soared This Week ↗

September 05, 2025

Via The Motley Fool

PTC Therapeutics Stock Is Stuck In A Multi-Year Slump ↗

August 21, 2025

Via Benzinga

PTC THERAPEUTICS INC (NASDAQ:PTCT) Emerges as a Top Affordable Growth Stock ↗

August 21, 2025

Via Chartmill

PTC Therapeutics Stock In The Spotlight After FDA Refuses Approval For Drug To Treat Neurodegenerative Disease, Analysts Are Divided ↗

August 19, 2025

Via Stocktwits

PTC Therapeutics Faces FDA Rejection On Rare Disease Treatment Over Efficacy Concerns ↗

August 19, 2025

Via Benzinga

Frequently Asked Questions

Is PTC Therapeutics, Inc. - Common Stock publicly traded?

Yes, PTC Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does PTC Therapeutics, Inc. - Common Stock trade on?

PTC Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for PTC Therapeutics, Inc. - Common Stock?

The ticker symbol for PTC Therapeutics, Inc. - Common Stock is PTCT on the Nasdaq Stock Market

What is the current price of PTC Therapeutics, Inc. - Common Stock?

The current price of PTC Therapeutics, Inc. - Common Stock is 75.56

When was PTC Therapeutics, Inc. - Common Stock last traded?

The last trade of PTC Therapeutics, Inc. - Common Stock was at 12/10/25 03:06 PM ET

What is the market capitalization of PTC Therapeutics, Inc. - Common Stock?

The market capitalization of PTC Therapeutics, Inc. - Common Stock is 6.04B

How many shares of PTC Therapeutics, Inc. - Common Stock are outstanding?

PTC Therapeutics, Inc. - Common Stock has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.